R-Pharm Group Introduced Cervical Cancer Screening Programme
OREANDA-NEWS. Experts of R-Pharm Group’s Laboratory Diagnostics and Medical Equipment Department put forward the initiative on launch of cervical cancer liquid-based cytology screening programme at the Third National Forum “Reproductive potential of Russia: women’s health is the health of nation. Kazanskie Chteniya”, held on February 27 – March 1, 2013 in Kazan.
The event attracted over 2,000 representatives of medical community, who paid special attention to women’s health and screening of women oncology diseases in particular. The participants of the event discussed the implementation of liquid-based cytology into gynecology. Experts of R-Pharm and Becton Dickinson companies showed the opportunities and benefits of contemporary closed systems including Rovers® Cervex-Brush and BD SurePath™ containers that significantly reduce the time of biomaterials’ withdrawal, maintain comfort conditions for patients and reduce the number of false-negative results. The closed container system allows preserving the biomaterial for up to 6 months in controlled temperature environment.
New agreements on supply of Rovers® сytology brushes and Becton Dickinson containers were signed as a result of participation in the event.